Literature DB >> 15047845

Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.

Ida Andersson1, Linda Bladh, Mehrdad Mousavi-Jazi, Karl-Eric Magnusson, Ake Lundkvist, Otto Haller, Ali Mirazimi.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) belongs to the genus Nairovirus within the family Bunyaviridae and is the causative agent of severe hemorrhagic fever. Despite increasing knowledge about hemorrhagic fever viruses, the factors determining their pathogenicity are still poorly understood. The interferon-induced MxA protein has been shown to have an inhibitory effect on several members of the Bunyaviridae family, but the effect of MxA against CCHFV has not previously been studied. Here, we report that human MxA has antiviral activity against CCHFV. The yield of progeny virus in cells constitutively expressing MxA was reduced up to 1,000-fold compared with control cells, and accumulation of viral genomes was blocked. Confocal microscopy revealed that MxA colocalizes with the nucleocapsid protein (NP) of CCHFV in the perinuclear regions of infected cells. Furthermore, we found that MxA interacted with NP by using a coimmunoprecipitation assay. We also found that an amino acid substitution (E645R) within the C-terminal domain of MxA resulted in a loss of MxA antiviral activity and, concomitantly, in the capacity to interact with CCHFV NP. These results suggest that MxA, by interacting with a component of the nucleocapsid, prevents replication of CCHFV viral RNA and thereby inhibits the production of new infectious virus particles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047845      PMCID: PMC374267          DOI: 10.1128/jvi.78.8.4323-4329.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures.

Authors:  F Flohr; S Schneider-Schaulies; O Haller; G Kochs
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

Review 2.  Garrotes, springs, ratchets, and whips: putting dynamin models to the test.

Authors:  S Sever; H Damke; S L Schmid
Journal:  Traffic       Date:  2000-05       Impact factor: 6.215

3.  The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum.

Authors:  Molly A Accola; Bing Huang; Azzah Al Masri; Mark A McNiven
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

4.  Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers.

Authors:  Georg Kochs; Markus Haener; Ueli Aebi; Otto Haller
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

5.  Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes.

Authors:  Georg Kochs; Christian Janzen; Heinz Hohenberg; Otto Haller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

6.  Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein.

Authors:  V Chieux; W Chehadeh; J Harvey; O Haller; P Wattré; D Hober
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

7.  Expression of human MxA protein in mosquito cells interferes with LaCrosse virus replication.

Authors:  T A Miura; J O Carlson; B J Beaty; R A Bowen; K E Olson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.

Authors:  E Gordien; O Rosmorduc; C Peltekian; F Garreau; C Bréchot; D Kremsdorf
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 9.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

10.  Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; A Schuster; M Bayer; J Pavlovic; V ter Meulen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more
  49 in total

Review 1.  Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends.

Authors:  Goro Kuno; Gwong-Jen J Chang
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 3.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

4.  Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Stephen D Carter; Rebecca Surtees; Cheryl T Walter; Antonio Ariza; Éric Bergeron; Stuart T Nichol; Julian A Hiscox; Thomas A Edwards; John N Barr
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

5.  A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.

Authors:  Stephanie Devignot; Eric Bergeron; Stuart Nichol; Ali Mirazimi; Friedemann Weber
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

6.  Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Authors:  Sara Akerström; Mehrdad Mousavi-Jazi; Jonas Klingström; Mikael Leijon; Ake Lundkvist; Ali Mirazimi
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection.

Authors:  Helen Karlberg; Yee-Joo Tan; Ali Mirazimi
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

8.  Cross-Reactive anti-Nucleocapsid Protein Immunity against Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus in Multiple Species.

Authors:  Merve Kalkan-Yazıcı; Elif Karaaslan; Nesibe Selma Çetin; Sevde Hasanoğlu; Filiz Güney; Ümit Zeybek; Mehmet Z Doymaz
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

9.  Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.

Authors:  Helen Karlberg; Gunnel Lindegren; Ali Mirazimi
Journal:  Open Virol J       Date:  2010-04-22

10.  RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Jessica R Spengler; Jenish R Patel; Ayan K Chakrabarti; Marko Zivcec; Adolfo García-Sastre; Christina F Spiropoulou; Éric Bergeron
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.